EADV report shows that risankizumab is a consistent performer in psoriasis
Risankizumab performed better in treating psoriasis that appears on the nails, hands and feet, palms and scalp sores.
EADV starts this week in Paris
The European Academy of Dermatology and Venerology (EADV) 2018 meeting takes this week in Paris. Visit our EADV conference news site to follow the developments from Paris.
